ARCHIVES

Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

Oncology Societies, Cancer Center, List Reform Principles

August 12, 1994

ACCC To Consider Cancer Act Changes HSA Problems

January 7, 1977

Study Suggests Biomarker For Resistance to Tamoxifen

March 25, 2011

Wilding named director, Univ. of Wisconsin Cancer Center.

January 30, 2004

Kidney Cancer Group Seeks Proposals; AACR Offers Award

November 17, 1995

AACR Completes List Of Symposia Chairpersons

April 22, 1988